Omega Fund Management Ltd

All filings by Omega Fund Management Ltd on record concern Cancervax Corp. Between 22 June 2007 and 5 August 2009, the trades on record add up to 10 filings.

Both buying and selling appear: 1 purchase worth €3.3M, against 9 sales worth €2.0M. Taken together, the purchases exceed the sales by €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2009: no purchases and 8 sales on the market.

The record was last updated on 6 August 2009 with an open-market sale (€76k) in Cancervax Corp. The last insider purchase was made public on 26 June 2007, 7,076 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.